INDIANOLA, Pa., June 8 /PRNewswire/ -- MEDRAD received Food and Drug Administration (FDA) clearance for use of its Continuum MR Infusion System in magnetic resonance (MR) environments up to and including 3.0 Tesla (T). The new FDA clearance enables clinicians working in the latest 3.0T environments to infuse medications, sedatives, and other drugs while benefiting from Continuum's ease-of-use and dose enhancements.
